title: An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care.
authors.affiliation: University of Colorado Health Science Center, Aurora, CO. Electronic address: david.crawford@ucdenver.edu.
authors.forename: E David
authors.initials: ED
authors.lastname: Crawford
authors.affiliation: Mid-Michigan Health Centers, Jackson, MI.
authors.forename: Matt T
authors.initials: MT
authors.lastname: Rosenberg
authors.affiliation: Department of Pathology, James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD.
authors.forename: Alan W
authors.initials: AW
authors.lastname: Partin
authors.affiliation: Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA.
authors.forename: Matthew R
authors.initials: MR
authors.lastname: Cooperberg
authors.affiliation: University of Colorado Health Science Center, Aurora, CO.
authors.forename: Michael
authors.initials: M
authors.lastname: Maccini
authors.affiliation: Department of Urology and Population Health, New York University, New York, NY.
authors.forename: Stacy
authors.initials: S
authors.lastname: Loeb
authors.affiliation: Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Curtis A
authors.initials: CA
authors.lastname: Pettaway
authors.affiliation: Atlantic Urology Clinics, Carolina Urologic Research Center, Myrtle Beach, SC.
authors.forename: Neal D
authors.initials: ND
authors.lastname: Shore
authors.affiliation: University of Colorado Health Science Center, Aurora, CO.
authors.forename: Paul
authors.initials: P
authors.lastname: Arangua
authors.affiliation: University of Colorado Health Science Center, Aurora, CO.
authors.forename: John
authors.initials: J
authors.lastname: Hoenemeyer
authors.affiliation: Department of Urology, Department of Oncology, Kingston General Hospital, Queen's University, Kingston, ON.
authors.forename: Mike
authors.initials: M
authors.lastname: Leveridge
authors.affiliation: Department of Urology, University of California, San Francisco, San Francisco, CA.
authors.forename: Michael
authors.initials: M
authors.lastname: Leapman
authors.affiliation: National Cancer Institute, Center for Cancer Research, Bethesda, MD.
authors.forename: Peter
authors.initials: P
authors.lastname: Pinto
authors.affiliation: Department of Urology, The University of Texas Health Science Center at San Antonio, San Antonio, TX.
authors.forename: Ian M
authors.initials: IM
authors.lastname: Thompson
authors.affiliation: Department of Urology, University of California, San Francisco, San Francisco, CA.
authors.forename: Peter
authors.initials: P
authors.lastname: Carroll
authors.affiliation: Department of Urology, Memorial Sloan Kettering Cancer Institute, New York, NY.
authors.forename: James
authors.initials: J
authors.lastname: Eastham
authors.affiliation: Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.
authors.forename: Leonard
authors.initials: L
authors.lastname: Gomella
authors.affiliation: Cleveland Clinic, Glickman Urological & Kidney Institute, Cleveland, OH.
authors.forename: Eric A
authors.initials: EA
authors.lastname: Klein
mesh_terms: D055088:Early Detection of Cancer; D006801:Humans; D008297:Male; D017410:Practice Guidelines as Topic; D011320:Primary Health Care; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000175:diagnosis*
chemical_list: D017430:Prostate-Specific Antigen